🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For #Media #Investors #MoonLake is at #AAD2025! 📅 March 7–11 2025 📍 #MLTX booth, networking with attendees and VELA investigators 📢 Two E-posters on our #HS and #Nanobody® research For more info: [email protected]. #MLTX #PsA #IL17F

For #Media #Investors #MoonLake is attending the #LeerinkGlobalHealthcare Conference! 📅March 9–12 2025 📍Miami, Florida 📢Join our CEO & Co-Founder, Jorge Santos da Silva, at the Fireside Chat from 1:00–1:30PM on Wednesday, March 12. #MLTX #HS #Nanobody® #2025 #PsA #IL17F

For #Media #Investors Spotlight in @BusinessWeekly. With a presence in #Cambridge, the UK’s scientific hub for innovation, we’re thrilled to be seen as a growing player in biotech. Read: shorturl.at/tzThI. #Biotech #HS #IL17F #MLTX #MoonLake #Nanobody® #PsA #2025

New BioBoss podcast wyantsimboli.com/bioboss/jorge-… with Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics (NASDAQ: MLTX). Hear Jorge speak with BioBoss host and Wyant Simboli Group principal John Simboli about how MoonLake is working to develop therapies for people living with inflammatory diseases.

For #Media #Investors April 6th marked 3 years of #MoonLake listed on Nasdaq stock market under #MLTX. To celebrate this third anniversary, we were thrilled to be featured on the iconic Nasdaq tower in Times Square, NYC – watch our spotlight below! #HS #Nanobody® #PsA #IL17F

For #Media #Investors: Meet us at #EADVSymposium in Prague! 🗓️ 23 May | 09:00-09:20 CEST 📢 Novel Drug Technologies 🎙️ Prof. Dr. Kristian Reich We look forward to seeing you there! #MLTX #IL17F #HS #PsA #Dermatology #Nanobody®

For #Media #Investors: Next week, join us at the Dermatology Drug Development Summit Europe! 🗓️ 28 May | 09:00 and 11:30 am CEST 📢 Presentation and Panel Discussion on HS 🎙️ Prof. Dr. Kristian Reich 🔗 More info: tinyurl.com/DDDSummit #MLTX #IL17F #HS #Dermatology #Nanobody®

For #media #investors: We are proud to sponsor the 'Emerging Leaders in Inflammatory Skin Diseases' course. 📅 May 29–31, 2025 📍 Beth Israel Deaconess Medical Center, Boston Empowering exec leaders in #Dermatology to lead, influence and drive change. #IL17F #HS #PsA #Nanobody®

For #media #investors: This month we celebrated our 4-year anniversary 🎉 Hear from our CEO Jorge Santos da Silva as he reflects on all we have achieved - and looks ahead to what is next 🚀 #IL17F #Nanobody® #HS #PsA #MLTX

For #media #investors: We are heading to the Jefferies Global Healthcare Conference 2025 in NYC, June 3-5. 🗣️ Fireside Chat with Jorge Santos da Silva, Founder & CEO 📅 June 4 | 4:55–5:25 PM EDT 🔗 tinyurl.com/2u66wvm6 #MLTX #IL17F #HS #PsA #Nanobody® #JefferiesHealthcare

For #media #investors: This #HSAwarenessWeek, we stand with the millions of people affected by #HidradenitisSuppurativa. Through cutting-edge research, we are working to bring hope to those living with #HS. 🔗Find out more about the disease: hs-foundation.org/mission #MLTX #IL17F

For #media #investors: From June 9-10, meet us at the Goldman Sachs Annual Global Healthcare Conference in Miami Beach for a Fireside Chat with Jorge Santos da Silva, Founder & CEO: 📅 June 11 | 11:20–11:55 AM EDT ✉️ More info: [email protected] #MLTX #IL17F #HS #PsA #Nanobody®

For #media #investors: Meet us at #EULAR2025 in Barcelona, on June 11-14! Today, don't miss key ARGO data: 📋 Poster – Patient-Reported Outcomes – Prof. Laure Gossec, 3:30 PM CEST 🗣️ Oral presentation – Multidomain Clinical Outcomes – Prof. Ian McInnes, 5:40 PM #MLTX #IL17F #PsA

For #media #investors: That's a wrap on #EULAR2025! We are thrilled to have shared data on our ARGO trials in #PsoriaticArthritis with the rheumatology community. Thank you to Prof. Ian McInnes and Prof. Laure Gossec for their brilliant presentations. #MLTX #IL17F #PsA #Nanobody

For #media #investors: In this in-depth Investment Reports interview with our CEO, Jorge Santos da Silva, learn how we are advancing #Nanobody® technology to transform treatment in inflammatory diseases, starting with HS and PsA. 🔗 tinyurl.com/ye6aav6c #HS #PsA #IL17F #Biotech

For #media #investors: Get to know Prof. Dr. Kristian Reich, our co-Founder and Chief Scientific Officer, in this Drug Discovery World interview on the future of immunology and innovation in inflammatory disease. 🔗 Read it here: tinyurl.com/tm422zad #Nanobody® #HS #PsA #IL17F #Biotech